FLT4 and acute kidney injury: In contrast, Vegfr3 inhibition using soluble VEGFR3, anti-VEGFR3 antibodies or transgenic Vegfr3 overexpression approach demonstrated beneficial effects in multiple clinical models of AKI (131).